First human tests begin for new kidney disease treatment
NCT ID NCT07445906
Summary
This is an early safety study for a new injection called RG002C0106, which is being developed for IgA Nephropathy, a type of kidney disease. Researchers want to see how the drug behaves in the body and if it is safe in 24 healthy adults and adults with mild-to-moderate kidney problems. The main goal is to understand how reduced kidney function affects the drug's levels and safety after a single shot.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IGA NEPHROPATHY (IGAN) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.